Program Head, Lung Cancer

Description

Professor, Clinician-Scholar, Lung Cancer Program Head

The Fred Hutchinson Cancer Center (Fred Hutch) and the University of Washington (UW) invite nominations and applications for the Program Head of Lung Cancer. This role offers an exceptional opportunity to drive cutting‑edge research, enhance clinical outcomes, and lead a multidisciplinary team in a dynamic and supportive environment.

The position will be appointed in the Clinical Research Division (CRD) at Fred Hutch with a secondary appointment in the UW Department of the applicant’s specialty. It will report to the Senior Vice President (SVP) of the CRD at Fred Hutch and the appropriate Division Head and/or Department Chair at UW.

We are seeking a highly motivated, visionary and accomplished scientific and clinical leader to head the Lung Cancer Program at Fred Hutch. The Program Head will oversee and strategically guide the program, ensuring alignment with the institution’s mission and goals. They will develop and implement a comprehensive vision and strategy that integrates basic, translational and clinical research with clinical care, while promoting education and mentorship.

The incumbent will lead and/or support groundbreaking research initiatives in lung cancer, including preclinical studies, clinical trials and translational research, and will foster collaborations with bench researchers, translational researchers and clinical investigators at UW and Fred Hutch. The incumbent will serve as an academic, clinical and educational leader charged with organizing, directing and expanding the research efforts of an established team of clinical researchers who conduct clinical research and trials in lung cancer.

Responsibilities include assisting with faculty recruitment as well as oversight and mentorship of faculty, promotion of professional development for team members and representation of the program at national and international conferences, workshops and symposia. The incumbent will build and maintain strong relationships with external stakeholders, including industry partners, regulatory agencies and funding organizations.

Competitive candidates will have an international reputation of leadership in both lung cancer research and clinical excellence. They will have a long‑standing track record of substantial basic, translational and/or clinical research with consistent primary author high‑impact publications and/or grant funding.

Appointment at Fred Hutch would be at the rank of associate or full professor in the Clinical Research Division. Appointment to the full‑time faculty at UW would be at the rank of associate or full professor. Academic appointments at the University of Washington will be commensurate with experience, qualifications and academic rank. Associate and full professors hold indefinite appointments that align with a 12‑month service period (July 1 – June 30).

Faculty with 12‑month service periods are paid for 11 months of service over a 12‑month period (July – June), meaning the equivalent of one month is available for paid time off.

Opportunities exist for affiliate appointments in the Fred Hutch Divisions of Public Health Sciences, Translational Science and Therapeutics, Human Biology, Basic Sciences, or Vaccine and Infectious Disease, depending on mutual interests. Fred Hutch and University of Washington faculty engage in teaching, research and service.

The successful candidate will be appointed in the Clinician‑Scholar track and will spend approximately 30 % of time on clinical care. The remainder of the incumbent’s time will be protected for research, administrative oversight of the Fred Hutch/UW Lung Cancer program, teaching and mentorship.

Faculty are expected to perform their primary activities on‑site at Fred Hutch.

Fred Hutch is an independent, nonprofit organization providing adult cancer treatment and groundbreaking research focused on cancer and infectious diseases. Based in Seattle, Fred Hutch is the only National Cancer Institute‑designated cancer center in Washington.

With a track record of global leadership in bone marrow transplantation, HIV/AIDS prevention, immunotherapy and COVID‑19…